Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0000947871-25-000120

Director bought 550,000 shares at $18.00 ($9,900,000)

  • Director acquired 3,154,959 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

ORBIMED ADVISORS LLC · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-10 Conversion : show line 1 in the form +3,154,959 3,154,959 I
2025-02-10 Purchase : show line 2 in the form +550,000 $18.00 $9,900,000 3,704,959 I
Open-market purchases · 550,000 sh · avg $18.00 · $9,900,000

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-02-10 Conversion : show line 3 in the form Series B convertible preferred stock −2,560,951 0 I
2025-02-10 Conversion : show line 4 in the form Series C convertible preferred stock −2,048,760 0 I
Loading xslF345X05/ownership.xml…